PathKeeper Surgical Celebrates the First Spine Surgery Performed with the PathKeeper 3D Optical Navigation System in Massachusetts

PathKeeper Surgical, a privately-held, Israel-based, medical technology company, dedicated to improving the health of individuals around the world suffering from all spinal issues requiring surgery. While celebrating the first use of the PathKeeper 3D optical navigation system during a spinal fusion surgery at Southcoast Health’s St. Luke’s Hospital in New Bedford, Massachusetts, PathKeeper Surgical strives to make navigation-guided surgery available to any patient in all operating rooms.

The PathKeeper system was utilized to create a comprehensive surgical plan and accurately navigate the single-level, lumbar degenerative spinal fusion surgery at Southcoast Health’s St. Luke’s Hospital.

“The PathKeeper system addresses many of the intricacies of spine surgery and adjusts to individual patient needs with a high level of accuracy and no radiation during a crucial part of the surgical procedure,” said Matthew Philips, MD, Chief of Brain & Spine Services, Southcoast Health Neurosurgery, Dartmouth, MA. “We have already experienced the clinical benefits of incorporating the PathKeeper system into our spinal fusion surgeries at St. Luke’s Hospital.”

The PathKeeper system was designed to replace traditional navigation technology with a 3D optical navigation system that offers comprehensive surgical planning; active, independent, submillimeter registration and tracking of the patient anatomy and surgical instruments; pinpoint accuracy of device implantation; more efficient surgical workflow; elimination of radiation exposure during the surgical procedure; and a more economical price so both the hospital and ambulatory-surgical center operating rooms can incorporate this new technology.

“We are thrilled at the adoption of the PathKeeper system at Southcoast Health, which continues our expansion of the PathKeeper system to hospitals and surgery centers across the United States,” said Ryan LeBlanc, Chief Commercial Officer, PathKeeper Surgical. “The PathKeeper system is a game changer in driving improved clinical outcomes and economic value to patients and healthcare providers.”

PathKeeper Surgical received its FDA 510k clearance earlier this year for the PathKeeper system. The name PathKeeper effectively describes the essence of the system – a 3D optical navigation system that ‘keeps’ the surgical ‘path’ on course throughout the surgery.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”